Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry - Concepedia

Concepedia

Publication | Open Access

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

DOI Full Paper Access

65

Citations

11

References

2014

Year

G. Carretero, E. Daudén, Francisco Vanaclocha Sebastián, Francisco Gómez‐García, Enrique Herrera‐Ceballos, P. de la Cueva, I. Belinchón, J.L. Sánchez‐Carazo, M. Alsina‐Gibert, J.L. López‐Estebaranz,

Journal of the European Academy of Dermatology and Venereology

Abstract

Patients receiving biologics had lower risk of AE. We did not find differences in the risk of serious or fatal AE.

References

	Year	Citations

Page 1